Spinal Surgery Devices Market: Global Market Analysis, Dynamics, Country Share, Trends, Competitor Analysis 2013 – 2017 and Forecast 2018 – 2025

Global Spinal Surgical Devices market is set to surpass US$ 12.5 Billion by 2025.
Market growth can be attributed to factors such as increasing preference for Minimally Invasive Spinal Surgery (MISS) procedures, increasing geriatric and obese population with increasing number of spine deformities and technological advancements in spine surgery devices are the key factors fuelling the growth of the spinal surgical devices market.
Spinal Surgical Devices Market: Country–wise Outlook
United States is expected to lead the spinal surgical devices market with a total market share of over 50% by 2025. Japan has shown its potential to become leading #2 market with more than XX% market share in 2017 and is expected to maintain its #2 position during the forecast period. China is expected to become the third largest spinal surgical devices market by 2025.
Spinal Surgical Devices Market: Key Players Outlook
DePuy Synthes dominates the global spinal surgical devices market. Medtronic captured second highest share of the global spinal surgical devices market in 2017 and is expected to maintain its position till the forecast period. Nuvasive and Zimmer Bionet is competing closely with each other to grab maximum share of the global spinal surgical devices market.
The report titled “Spinal Surgery Devices Market: Global Market Analysis, Dynamics, Country Share, Trends, Competitor Analysis 2013 – 2017 and Forecast 2018 – 2025”examines the market, demand, competitive landscape and trends of the ten major markets of the spinal surgical devices market. It provides essential insights into spinal surgical devices market for the top 10 countries, comprising the US, the UK, France, Italy, Spain, Germany, Japan, China, India and Brazil until 2025. Key trends in terms of collaborations, partnerships, licensing and development agreements, merger and acquisition and distribution agreement are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the spinal surgery devices market.
The report concludes with the profiles of major players in the spinal surgery devices market. The major market players are evaluated on various parameters such as company overview, market revenue and latest development and trends of the spinal surgery devices market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Medtronic, Zimmer Bionet, Stryker, DePuy Synthes, NuVasive, Globus Medical, Orthofix International, K2M Medical, SeaSpine, Alphatec Holdings
Ten Major Markets(10MM) Covered in the Report are as follows:
United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India, Brazil
The Latest Industry Data Included in this Report:
• Global Spinal Surgical Devices Market & Forecast (2013 – 2025)
• Global Spinal Surgical Devices Market Share & Y-o-Y Growth (%)
• Global Spinal Surgical Devices Market Share, by Major Companies, 2013 – 2025
• Global Spinal Surgical Devices Market Share by Major Countries, 2013 – 2025
• Global Spinal Surgical Devices Market, By Geography, 2013 – 2025
• Major Deals in Spinal Surgical Devices Market
• Major Companies Market Revenue & Forecast (2013 – 2025)
• Major Companies Latest Development & Trends
• Market Definition for the Specified Topic Along with Identification of Key Drivers
   and Inhibitors for the Market
Advertisements

Global Insulin Delivery Pen Market 2018

Insulin Delivery Pen Market is expected to exceed US$ 14 Billion across the ten major markets (10MM) by 2025.
The report “Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 – 2017) and Future Forecast (2018 – 2025)” offers the most up-to-date industry data on the actual market situation and future outlook for insulin pen across the ten major markets (10MM). The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025. A comprehensive analysis has been done on market share of insulin pen segment.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd.
Key Findings:
• Germany accounted for 15% of the insulin delivery pen market in 2017
• China dominates the reusable insulin delivery pen market
• Reusable insulin delivery pen has the highest volume share in the overall insulin delivery pen market
• Disposable insulin delivery pen is expected to register a faster value growth during 2018-2025
• Japan is the third largest insulin delivery pen market
• Flexpen, Solostar and KwikPen are the leading brand in the insulin delivery pen sector
The Latest Industry Data Included in this Report:
• Diabetes Population in 10 major market(10MM) 2011-2025
• Insulin Users Insights in 10 major market(10MM) 2011-2025
• Overall Insulin Delivery Pen Users, 2011-2025
• Overall Insulin Delivery Pen Market Size, 2011-2025
• Insulin Delivery Pen Market Size by Product Segments, 2011-2025
• Growth Rates of the Overall Market and Different Product Segments, 2011-2025
• Shares of Different Product Segments of the Overall Market, 2011- 2025
• Market Definition for the Specified Topic Along with Identification of Key Drivers
   and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
  Product Portfolios and Recent Development
The Report Facilitates Answer the Subsequent Questions:
• What is the size of the insulin delivery pen market in 10 major market(10MM)?
• How much reusable and disposable pen users in 10 major market(10MM)?
• How is the insulin delivery pen market divided into two different types of segments?
• How are the overall market and segments types growing?
• How is the market predicted to develop in the future?
• Who are the market players?

Advanced Oncotherapy (AVO) Selects RayStation for the First LIGHT System in Central London

Source: https://www.prnewswire.com/news-releases/advanced-oncotherapy-avo-selects-raystation-for-the-first-light-system-in-central-london-300676566.html

The UK based developer of next generation proton therapy technology, Advanced Oncotherapy plc (AVO), has selected RayStation as its treatment planning system for the first LIGHT (Linac Image Guided Hadron Technology) system at the proton therapy facility under construction at Harley Street in central London. Users at the clinic will have access to the full spectrum of RayStation’s functionality.

AVO and RaySearch have entered into a collaboration agreement to support the LIGHT system fully. The LIGHT system is a modular proton therapy system based on innovative technology, developed in a collaboration between the TERA project and CERN in Geneva, Switzerland. The heart of the system consists of a treatment room integrated with a linear accelerator, which accelerates protons to energies suitable for radiation therapy of cancer. The entire system is designed for cost effectiveness and low maintenance and has several key features, such as multiple spot sizes and fast energy switching time.

The order of RayStation for Harley street gives the users access to the full spectrum of RayStation’s functionality, including the fast proton Monte Carlo dose engine, robust 4D optimization, LET driven optimization, deformable registration, dose accumulation, plan adaptation, multi-criteria optimization and Plan Explorer for automatic plan generation.

Nicolas Serandour, AVO Chief Executive Officer, says: “We are thrilled to collaborate with RaySearch. RaySearch has established themselves as the technology of choice for light ion therapy treatment planning. As we bring our advanced particle therapy treatment technology into the field, it makes sense to have the most advanced treatment planning capability to complement it. We believe the synergetic combination is significant for optimizing patient care at our first proton therapy center in the renowned medical practice area of Harley Street, London.”

Global Non-Invasive Prenatal Testing Market Development Trends, Key Manufacturers and Competitive Analysis Research Report Forecast 2018 to 2025

Global Non-Invasive Prenatal Testing(NIPT) market is anticipated to grow over US$ 2.5 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025. 
The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non-invasive techniques over invasive methods.
“Global Non-Invasive Prenatal Testing Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025” presents an in-depth assessment of the Global Non-Invasive Prenatal Testing (NIPT) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for Global Non-Invasive Prenatal Testing (NIPT). The research includes historic data from 2014 to 2017 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of NIPT tests and Countries-based market. The report also includes assessment of comparative test analysis by companies. Additionally, the report includes insights into the Global perspectives on clinical adoption of NIPT. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Non-Invasive Prenatal Testing (NIPT) market.
The report concludes with the profiles of major players in the Global Non-Invasive Prenatal Testing (NIPT) market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolios and latest development and trends of the Non-Invasive Prenatal Testing (NIPT) market.
Key Findings:
• United States is anticipated to be the most attractive market in the Global Non-Invasive Prenatal Testing(NIPT) market
• China NIPT test market is set to cross USD 400 Million by 2025
• Panorama test accounted for the highest share in Global Non-Invasive Prenatal Testing(NIPT) market
• Verifi test has the second highest revenue share in the Global Non-Invasive Prenatal Testing(NIPT) market
• Rising focus on Reimbursement for NIPT test will revolutionize the market
• Two–Child policy is likely to boost China NIPT market
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
 
Illumina, Natera, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche), BGI Diagnosis Co. Ltd, Berry Genomics, Quest Diagnostics, LifeCodexx AG, Premaitha Health, NIPD Genetics
Major and Promising Non-Invasive Prenatal Testing (NIPT) Covered Under This Report are:
Panorama, MaterniT21 PLUS, Harmony, Verifi, NIFTY, IONA, PrenaTest, Bambni, Veracity and Other Tests
Major Countries Analyzed Under This Report are:
United States, China, Japan, India, Brazil, Australia, New Zealand, United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark and Rest of the Countries.
The Latest Industry Data Included in this Report:
• Global Non–Invasive Prenatal Testing Market Volume & Future Trends (2014 – 2025)
• Global Non–Invasive Prenatal Testing Market Revenue & Future Trends (2014 – 2025)
• Global Non–Invasive Prenatal Testing Market Share and Y–o–Y Growth (%)
• Market Share Analysis, by Test, 2014 – 2025 (%)
• Market Share Analysis, by Major Countries, 2014 – 2025 (%)
• Global Non–Invasive Prenatal Testing Market, By Test (Volume and Value),2011 – 2025
• Global Non–Invasive Prenatal Testing Market, By Geography (Volume and Value),2014 – 2025
• Non–Invasive Prenatal Testing(NIPT) Comparative Analysis – By Test
• Major Deals in Global Non–Invasive Prenatal Testing Market
• Global Perspectives on Clinical Adoption of NIPT
• Global Non–Invasive Prenatal Testing Market Drivers and Inhibitors
• Key Companies Analysis

China In Vitro Diagnostic Market Promising development scope 2025

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.
The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.
“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025: Clinical Chemistry, Immunoassay, Molecular Testing, SMBG, Point of Care Testing (POCT), Hematology, Coagulation, Microbiology, Genetic Testing, Infectious Diagnostics, Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.
The report contains a granular analysis of the China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025. A comprehensive analysis has been done on market share of China in vitro diagnostics by application, end-user and company share by revenue.
The report also includes assessment of in vitro diagnostics regulation in China. Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers, restraints, trends and opportunities of the China in vitro diagnostics market.
Market Segmentation by Application and Analysis (2012 – 2025)
•Clinical Chemistry
• Immunoassay
•Molecular Testing
• Self–Monitoring of Blood Glucose (SMBG)
•Point of Care Testing (POCT)
•Hematology
•Coagulation
•Microbiology
• Genetic Testing
• Infectious Diagnostics
• Histology and Cytology
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Sysmex Corporation
• Mindray Medical International Limited
• Beckman Coulter Inc
• Shanghai Fosun Pharmaceutical Group
• Thermo Fisher Scientific Inc
• Hologic Inc
• Qiagen
• Cepheid
• Bio-Rad Laboratories Inc
• Da An Gene Co. Ltd
• Shanghai Kehua Bio–Engineering Co. Ltd.
The Latest Industry Data Included in this Report:
• China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)
• China In Vitro Diagnostics Market Dynamics
• China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)
• China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)
• China In Vitro Diagnostics Market, Company Share by Revenue, 2017
• China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017
• Assessment of In Vitro Diagnostics Regulation in China
• Major Partnership Deals in China In Vitro Diagnostics Market
• Recent Developments in China In Vitro Diagnostics Market
• Overview of Key Companies in China In Vitro Diagnostics Market

Reimbursement for NIPT test will revolutionize the market in the Forecast

Global Non-Invasive Prenatal Testing(NIPT) market is anticipated to grow over US$ 2.5 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025. 
The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non-invasive techniques over invasive methods.
“Global Non-Invasive Prenatal Testing Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025” presents an in-depth assessment of the Global Non-Invasive Prenatal Testing (NIPT) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for Global Non-Invasive Prenatal Testing (NIPT). The research includes historic data from 2014 to 2017 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of NIPT tests and Countries-based market. The report also includes assessment of comparative test analysis by companies. Additionally, the report includes insights into the Global perspectives on clinical adoption of NIPT. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Non-Invasive Prenatal Testing (NIPT) market.
The report concludes with the profiles of major players in the Global Non-Invasive Prenatal Testing (NIPT) market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolios and latest development and trends of the Non-Invasive Prenatal Testing (NIPT) market.
Key Findings:
• United States is anticipated to be the most attractive market in the Global Non-Invasive Prenatal Testing(NIPT) market
• China NIPT test market is set to cross USD 400 Million by 2025
• Panorama test accounted for the highest share in Global Non-Invasive Prenatal Testing(NIPT) market
• Verifi test has the second highest revenue share in the Global Non-Invasive Prenatal Testing(NIPT) market
• Rising focus on Reimbursement for NIPT test will revolutionize the market
• Two–Child policy is likely to boost China NIPT market
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
 
Illumina, Natera, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche), BGI Diagnosis Co. Ltd, Berry Genomics, Quest Diagnostics, LifeCodexx AG, Premaitha Health, NIPD Genetics
Major and Promising Non-Invasive Prenatal Testing (NIPT) Covered Under This Report are:
Panorama, MaterniT21 PLUS, Harmony, Verifi, NIFTY, IONA, PrenaTest, Bambni, Veracity and Other Tests
Major Countries Analyzed Under This Report are:
United States, China, Japan, India, Brazil, Australia, New Zealand, United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark and Rest of the Countries.
The Latest Industry Data Included in this Report:
• Global Non–Invasive Prenatal Testing Market Volume & Future Trends (2014 – 2025)
• Global Non–Invasive Prenatal Testing Market Revenue & Future Trends (2014 – 2025)
• Global Non–Invasive Prenatal Testing Market Share and Y–o–Y Growth (%)
• Market Share Analysis, by Test, 2014 – 2025 (%)
• Market Share Analysis, by Major Countries, 2014 – 2025 (%)
• Global Non–Invasive Prenatal Testing Market, By Test (Volume and Value),2011 – 2025
• Global Non–Invasive Prenatal Testing Market, By Geography (Volume and Value),2014 – 2025
• Non–Invasive Prenatal Testing(NIPT) Comparative Analysis – By Test
• Major Deals in Global Non–Invasive Prenatal Testing Market
• Global Perspectives on Clinical Adoption of NIPT
• Global Non–Invasive Prenatal Testing Market Drivers and Inhibitors
• Key Companies Analysis

Global Non-Invasive Prenatal Testing Market:Illumina, Natera, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche), BGI Diagnosis Co. Ltd, Berry Genomics, Quest Diagnostics, LifeCodexx AG, Premaitha Health, NIPD Genetics

Global Non-Invasive Prenatal Testing(NIPT) market is anticipated to grow over US$ 2.5 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025. 
 
The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non-invasive techniques over invasive methods.
 
“Global Non-Invasive Prenatal Testing Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025” presents an in-depth assessment of the Global Non-Invasive Prenatal Testing (NIPT) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for Global Non-Invasive Prenatal Testing (NIPT). The research includes historic data from 2014 to 2017 and forecasts until 2025.
 
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of NIPT tests and Countries-based market. The report also includes assessment of comparative test analysis by companies. Additionally, the report includes insights into the Global perspectives on clinical adoption of NIPT. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Non-Invasive Prenatal Testing (NIPT) market.
 
The report concludes with the profiles of major players in the Global Non-Invasive Prenatal Testing (NIPT) market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolios and latest development and trends of the Non-Invasive Prenatal Testing (NIPT) market.
 
Key Findings:
 
• United States is anticipated to be the most attractive market in the Global Non-Invasive Prenatal Testing(NIPT) market 
• China NIPT test market is set to cross USD 400 Million by 2025
• Panorama test accounted for the highest share in Global Non-Invasive Prenatal Testing(NIPT) market
• Verifi test has the second highest revenue share in the Global Non-Invasive Prenatal Testing(NIPT) market 
• Rising focus on Reimbursement for NIPT test will revolutionize the market
• Two–Child policy is likely to boost China NIPT market
 
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
 
Illumina, Natera, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche), BGI Diagnosis Co. Ltd, Berry Genomics, Quest Diagnostics, LifeCodexx AG, Premaitha Health, NIPD Genetics
 
Major and Promising Non-Invasive Prenatal Testing (NIPT) Covered Under This Report are:
 
Panorama, MaterniT21 PLUS, Harmony, Verifi, NIFTY, IONA, PrenaTest, Bambni, Veracity and Other Tests 
 
Major Countries Analyzed Under This Report are:
 
United States, China, Japan, India, Brazil, Australia, New Zealand, United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark and Rest of the Countries.
 
The Latest Industry Data Included in this Report:
 
• Global Non–Invasive Prenatal Testing Market Volume & Future Trends (2014 – 2025)
• Global Non–Invasive Prenatal Testing Market Revenue & Future Trends (2014 – 2025)
• Global Non–Invasive Prenatal Testing Market Share and Y–o–Y Growth (%)
• Market Share Analysis, by Test, 2014 – 2025 (%)
• Market Share Analysis, by Major Countries, 2014 – 2025 (%)
• Global Non–Invasive Prenatal Testing Market, By Test (Volume and Value),2011 – 2025
• Global Non–Invasive Prenatal Testing Market, By Geography (Volume and Value),2014 – 2025
• Non–Invasive Prenatal Testing(NIPT) Comparative Analysis – By Test
• Major Deals in Global Non–Invasive Prenatal Testing Market
• Global Perspectives on Clinical Adoption of NIPT
• Global Non–Invasive Prenatal Testing Market Drivers and Inhibitors
• Key Companies Analysis